Off-label GLP-1 receptor agonist and tirzepatide use for weight loss: Patient safety and regulatory oversight

Document Type

Editorial

Department

Medicine

Comments

Abstract is not provided by the author/publisher.

Publication (Name of Journal)

Ann Med Surg (Lond)

DOI

10.1097/MS9.0000000000005191

Share

COinS